{"transactions":[{"id":703491,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:51.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":184361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 184,361 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 52,358 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 184,361 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 52,358 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 184,361 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 52,358 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":184361},"source":{"system":"sec-edgar","filing":"0001140361-26-029633","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029633/form4.xml","form_type":"4"}},{"id":703490,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:51.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":26728,"price":13.82,"value":369380.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 26,728 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":862448,"source":{"system":"sec-edgar","filing":"0001140361-26-029633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029633/form4.xml","form_type":"4"}},{"id":703489,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:51.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":52358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 52,358 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":889176,"source":{"system":"sec-edgar","filing":"0001140361-26-029633","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029633/form4.xml","form_type":"4"}},{"id":705174,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4223,"price":13.71,"value":57897.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The exempt disposition of 4,223 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":836818,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705173,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":487,"price":13.51,"value":6579.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The exempt disposition of 487 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024."}],"balance_after":841041,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705172,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":11764,"price":13.51,"value":158931.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 11,764 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":841528,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705171,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":10649,"price":13.51,"value":143867.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 10,649 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":853292,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":705170,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-22T00:17:04.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":18588,"price":14.14,"value":262834.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 18,588 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":863941,"source":{"system":"sec-edgar","filing":"0001140361-26-029178","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036126029178/form4.xml","form_type":"4"}},{"id":1020802,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-10T01:09:24.000Z","date":"2025-10-09","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.15,"value":111500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $11.10 to $11.17 inclusive.  The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":882529,"source":{"system":"sec-edgar","filing":"0001140361-25-037836","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125037836/form4.xml","form_type":"4"}},{"id":1083333,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":3673,"price":8.99,"value":33020.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The exempt disposition of 3,673 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":872529,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083332,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2982,"price":8.69,"value":25913.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 2,982 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":876202,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083331,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":8307,"price":8.69,"value":72187.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 8,307 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":879184,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1083330,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:18.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":344,"price":8.69,"value":2989.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 344 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024."}],"balance_after":887491,"source":{"system":"sec-edgar","filing":"0001140361-25-026797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026797/form4.xml","form_type":"4"}},{"id":1084661,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:27.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":206253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":206253,"derivative":{"underlying":"Common Stock","underlying_shares":206253},"source":{"system":"sec-edgar","filing":"0001140361-25-026464","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026464/form4.xml","form_type":"4"}},{"id":1084660,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:27.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":206253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 206,253 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 206,253 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":887835,"source":{"system":"sec-edgar","filing":"0001140361-25-026464","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036125026464/form4.xml","form_type":"4"}},{"id":1389266,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-10-08T20:32:02.000Z","date":"2024-10-07","kind":"purchase","planned":true,"acquired":true,"shares":20000,"price":6.03,"value":120600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $5.95 to $6.08 inclusive.  The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":681582,"source":{"system":"sec-edgar","filing":"0001140361-24-043157","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124043157/form4.xml","form_type":"4"}},{"id":1442810,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2024-08-03T01:53:26.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":52378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 52,378 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 56,279 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52378},"source":{"system":"sec-edgar","filing":"0001140361-24-035600","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124035600/form4.xml","form_type":"4"}},{"id":1442809,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-08-03T01:53:26.000Z","date":"2024-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":28730,"price":7.4,"value":212602.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 28,730 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021."}],"balance_after":661582,"source":{"system":"sec-edgar","filing":"0001140361-24-035600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124035600/form4.xml","form_type":"4"}},{"id":1442808,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-08-03T01:53:26.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":56279,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 56,279 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021."}],"balance_after":690312,"source":{"system":"sec-edgar","filing":"0001140361-24-035600","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124035600/form4.xml","form_type":"4"}},{"id":1448642,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-26T01:00:19.000Z","date":"2024-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":3372,"price":7.13,"value":24042.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,372 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares of underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":634033,"source":{"system":"sec-edgar","filing":"0001140361-24-034270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124034270/form4.xml","form_type":"4"}},{"id":1448641,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-26T01:00:19.000Z","date":"2024-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2982,"price":7.13,"value":21261.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,982 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":637405,"source":{"system":"sec-edgar","filing":"0001140361-24-034270","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124034270/form4.xml","form_type":"4"}},{"id":1449894,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-23T22:36:22.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":7466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 19, 2025, such that 25% of the options will vest on each of July 19, 2025, 2026, 2027 and 2028."}],"balance_after":7466,"derivative":{"exercise_price":7.18,"exercise_date":"2025-07-19","expiration_date":"2034-07-19","underlying":"Common Stock","underlying_shares":7466},"source":{"system":"sec-edgar","filing":"0001140361-24-033912","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033912/form4.xml","form_type":"4"}},{"id":1449893,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2024-07-23T22:36:22.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":7633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":7633,"derivative":{"underlying":"Common Stock","underlying_shares":7633},"source":{"system":"sec-edgar","filing":"0001140361-24-033912","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033912/form4.xml","form_type":"4"}},{"id":1449892,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T22:36:22.000Z","date":"2024-07-19","kind":"grant","planned":false,"acquired":true,"shares":3817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 3,817 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,817 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2025, such that 25% of the restricted stock units will vest on each of July 19, 2025, 2026, 2027 and 2028."}],"balance_after":640387,"source":{"system":"sec-edgar","filing":"0001140361-24-033912","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033912/form4.xml","form_type":"4"}},{"id":1449891,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-23T10:01:29.000Z","date":"2024-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":8307,"price":7.18,"value":59644.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 8,307 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":636570,"source":{"system":"sec-edgar","filing":"0001140361-24-033784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033784/form4.xml","form_type":"4"}},{"id":1451147,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-19T21:18:31.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":207693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 17, 2025, such that 25% of the options will vest on each of July 17, 2025, 2026, 2027 and 2028."}],"balance_after":207693,"derivative":{"exercise_price":7.4,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":207693},"source":{"system":"sec-edgar","filing":"0001140361-24-033635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033635/form4.xml","form_type":"4"}},{"id":1451146,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2024-07-19T21:18:31.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":211622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":211622,"derivative":{"underlying":"Common Stock","underlying_shares":211622},"source":{"system":"sec-edgar","filing":"0001140361-24-033635","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033635/form4.xml","form_type":"4"}},{"id":1451145,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-19T21:18:31.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":105811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 105,811 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 105,811 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 17, 2025, such that 25% of the restricted stock units will vest on each of July 17, 2025, 2026, 2027 and 2028."}],"balance_after":644877,"source":{"system":"sec-edgar","filing":"0001140361-24-033635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124033635/form4.xml","form_type":"4"}},{"id":1545545,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-08T20:30:17.000Z","date":"2024-04-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":6.7,"value":67000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.64 to $6.76, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":539066,"source":{"system":"sec-edgar","filing":"0001140361-24-018620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036124018620/form4.xml","form_type":"4"}},{"id":1775362,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2023-09-22T01:07:13.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":108871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 108,871 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 69,676 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 108,871 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 69,676 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 108,871 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 69,676 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":108871},"source":{"system":"sec-edgar","filing":"0001140361-23-044830","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123044830/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775361,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-22T01:07:13.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":34296,"price":8.92,"value":305920.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 34,296 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":564446,"source":{"system":"sec-edgar","filing":"0001140361-23-044830","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123044830/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775360,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-09-22T01:07:13.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":69676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 69,676 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":598742,"source":{"system":"sec-edgar","filing":"0001140361-23-044830","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123044830/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1822797,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2023-07-27T01:32:45.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":108871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":108871},"source":{"system":"sec-edgar","filing":"0001140361-23-036322","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123036322/form4.xml","form_type":"4"}},{"id":1822796,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-27T01:32:45.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":11379,"price":8.92,"value":101500.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 11,379 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":549259,"source":{"system":"sec-edgar","filing":"0001140361-23-036322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123036322/form4.xml","form_type":"4"}},{"id":1822795,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-27T01:32:45.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":31572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 31,572 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":560638,"source":{"system":"sec-edgar","filing":"0001140361-23-036322","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123036322/form4.xml","form_type":"4"}},{"id":1823466,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-25T23:07:05.000Z","date":"2023-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":3372,"price":8.65,"value":29167.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,372 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":529066,"source":{"system":"sec-edgar","filing":"0001140361-23-036120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123036120/form4.xml","form_type":"4"}},{"id":1823465,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-25T23:07:05.000Z","date":"2023-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2982,"price":8.74,"value":26062.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,982 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":532438,"source":{"system":"sec-edgar","filing":"0001140361-23-036120","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123036120/form4.xml","form_type":"4"}},{"id":1824778,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-22T01:11:16.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":190778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 19, 2024, such that 25% of the options will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":190778,"derivative":{"exercise_price":8.92,"exercise_date":"2024-07-19","expiration_date":"2033-07-19","underlying":"Common Stock","underlying_shares":190778},"source":{"system":"sec-edgar","filing":"0001140361-23-035729","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123035729/form4.xml","form_type":"4"}},{"id":1824777,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2023-07-22T01:11:16.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":184361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":184361,"derivative":{"underlying":"Common Stock","underlying_shares":184361},"source":{"system":"sec-edgar","filing":"0001140361-23-035729","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123035729/form4.xml","form_type":"4"}},{"id":1824776,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-22T01:11:16.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":92181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 92,181 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 92,181 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2024, such that 25% of the restricted stock units will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":535420,"source":{"system":"sec-edgar","filing":"0001140361-23-035729","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123035729/form4.xml","form_type":"4"}},{"id":1827779,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-19T00:13:35.000Z","date":"2023-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2262,"price":9.56,"value":21624.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,262 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":443239,"source":{"system":"sec-edgar","filing":"0001140361-23-035086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123035086/form4.xml","form_type":"4"}},{"id":1827778,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-07-19T00:13:35.000Z","date":"2023-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":4906,"price":9.63,"value":47244.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 4,906 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":445501,"source":{"system":"sec-edgar","filing":"0001140361-23-035086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036123035086/form4.xml","form_type":"4"}},{"id":2139154,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-10-11T20:06:01.000Z","date":"2022-10-10","kind":"purchase","acquired":true,"shares":10000,"price":15,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.93 to $15.02, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":450407,"source":{"system":"sec-edgar","filing":"0001567619-22-018410","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922018410/doc1.xml","form_type":"4"}},{"id":2203255,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2022-07-22T22:47:30.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":77530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 20, 2023, such that 25% of the options will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":77530,"derivative":{"exercise_price":21.53,"exercise_date":"2023-07-20","expiration_date":"2032-07-20","underlying":"Common Stock","underlying_shares":77530},"source":{"system":"sec-edgar","filing":"0001567619-22-014379","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922014379/doc1.xml","form_type":"4"}},{"id":2203254,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2022-07-22T22:47:30.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":66187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":66187,"derivative":{"underlying":"Common Stock","underlying_shares":66187},"source":{"system":"sec-edgar","filing":"0001567619-22-014379","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922014379/doc1.xml","form_type":"4"}},{"id":2203253,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-22T22:47:30.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":33094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 33,094 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 33,094 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 20, 2023, such that 25% of the restricted stock units will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":440407,"source":{"system":"sec-edgar","filing":"0001567619-22-014379","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922014379/doc1.xml","form_type":"4"}},{"id":2209195,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2022-07-11T10:08:36.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":50139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 25,123 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 25,123 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 25,123 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50139},"source":{"system":"sec-edgar","filing":"0001567619-22-013842","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922013842/doc1.xml","form_type":"4"}},{"id":2209194,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-11T10:08:36.000Z","date":"2022-07-07","kind":"tax_withholding","acquired":false,"shares":8574,"price":20.54,"value":176109.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 8,574 shares of Common Stock to the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019."}],"balance_after":407313,"source":{"system":"sec-edgar","filing":"0001567619-22-013842","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922013842/doc1.xml","form_type":"4"}},{"id":2209193,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-11T10:08:36.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":25123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 25,123 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019"}],"balance_after":415887,"source":{"system":"sec-edgar","filing":"0001567619-22-013842","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922013842/doc1.xml","form_type":"4"}},{"id":2436786,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-01-12T21:35:13.000Z","date":"2022-01-11","kind":"purchase","acquired":true,"shares":10000,"price":22.84,"value":228400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.58 to $23.06, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":390764,"source":{"system":"sec-edgar","filing":"0001567619-22-001113","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761922001113/doc1.xml","form_type":"4"}},{"id":2456131,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-30T22:59:37.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":101667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."}],"balance_after":101667,"derivative":{"exercise_price":26.49,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":101667},"source":{"system":"sec-edgar","filing":"0001567619-21-022713","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921022713/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2456130,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2021-12-30T22:59:37.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":74840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."}],"balance_after":74840,"derivative":{"underlying":"Common Stock","underlying_shares":74840},"source":{"system":"sec-edgar","filing":"0001567619-21-022713","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921022713/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2456129,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-30T22:59:37.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":37420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report the acquisition and granting of shares of restricted stock units, performance rights and stock options of AngioDynamics, Inc. (the \"Company\") which contained administrative errors as to the number of restricted stock units, performance rights and stock options granted and the exercise price of such options."},{"field":"shares","element":"transactionShares","label":"F2","text":"The acquisition of 37,420 shares of common stock (\"Common Stock\") of the Company represents 37,420 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":372503,"source":{"system":"sec-edgar","filing":"0001567619-21-022713","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921022713/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2597803,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2021-08-18T11:08:17.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":34938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 34,938 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 40,528 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 34,938 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 40,528 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 34,938 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 40,528 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":34938},"source":{"system":"sec-edgar","filing":"0001567619-21-016023","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921016023/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2597802,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-18T11:08:17.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":21532,"price":27.29,"value":587608.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold."},{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 21,532 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018."}],"balance_after":378163,"source":{"system":"sec-edgar","filing":"0001567619-21-016023","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921016023/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2597801,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-18T11:08:17.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":40528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold."},{"field":"shares","element":"transactionShares","label":"F2","text":"This acquisition of 40,528 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018."}],"balance_after":399695,"source":{"system":"sec-edgar","filing":"0001567619-21-016023","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921016023/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2600095,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2021-08-17T10:49:20.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":50139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 50,139 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50139},"source":{"system":"sec-edgar","filing":"0001567619-21-015951","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921015951/doc1.xml","form_type":"4"}},{"id":2600094,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-17T10:49:20.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":9021,"price":27.29,"value":246183.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 9,021 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019."}],"balance_after":369533,"source":{"system":"sec-edgar","filing":"0001567619-21-015951","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921015951/doc1.xml","form_type":"4"}},{"id":2600093,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-17T10:49:20.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":19387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 19,387 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019."}],"balance_after":378554,"source":{"system":"sec-edgar","filing":"0001567619-21-015951","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921015951/doc1.xml","form_type":"4"}},{"id":2623797,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-27T22:43:00.000Z","date":"2021-07-26","kind":"tax_withholding","acquired":false,"shares":2105,"price":26.1,"value":54940.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,105 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":359167,"source":{"system":"sec-edgar","filing":"0001567619-21-014055","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921014055/doc1.xml","form_type":"4"}},{"id":2625851,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-23T22:42:38.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":71154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":71154,"derivative":{"exercise_price":10.27,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":71154},"source":{"system":"sec-edgar","filing":"0001567619-21-013917","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921013917/doc1.xml","form_type":"4"}},{"id":2625850,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2021-07-23T22:42:38.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":52378,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":52378,"derivative":{"underlying":"Common Stock","underlying_shares":52378},"source":{"system":"sec-edgar","filing":"0001567619-21-013917","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921013917/doc1.xml","form_type":"4"}},{"id":2625849,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-23T22:42:38.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":26189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The acquisition of 26,189 shares of Common Stock  of the Company represents 26,189 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":361272,"source":{"system":"sec-edgar","filing":"0001567619-21-013917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921013917/doc1.xml","form_type":"4"}},{"id":2625848,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-23T22:42:38.000Z","date":"2021-07-18","kind":"tax_withholding","acquired":false,"shares":1483,"price":24.76,"value":36719.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 1,483 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":335083,"source":{"system":"sec-edgar","filing":"0001567619-21-013917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921013917/doc1.xml","form_type":"4"}},{"id":2625847,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-23T22:42:38.000Z","date":"2021-07-17","kind":"tax_withholding","acquired":false,"shares":2131,"price":24.76,"value":52763.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,131 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":336566,"source":{"system":"sec-edgar","filing":"0001567619-21-013917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921013917/doc1.xml","form_type":"4"}},{"id":2625846,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-23T22:42:38.000Z","date":"2021-07-14","kind":"tax_withholding","acquired":false,"shares":4622,"price":26.43,"value":122159.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 4,622 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":338697,"source":{"system":"sec-edgar","filing":"0001567619-21-013917","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761921013917/doc1.xml","form_type":"4"}},{"id":3071286,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-08-03T21:27:43.000Z","date":"2020-07-31","kind":"purchase","acquired":true,"shares":40000,"price":8.26,"value":330400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.24 to $8.26, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":343319,"source":{"system":"sec-edgar","filing":"0001567619-20-014068","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920014068/doc1.xml","form_type":"4"}},{"id":3074821,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-28T20:38:12.000Z","date":"2020-07-27","kind":"tax_withholding","acquired":false,"shares":1799,"price":8.8,"value":15831.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,799 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":303319,"source":{"system":"sec-edgar","filing":"0001567619-20-013825","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013825/doc1.xml","form_type":"4"}},{"id":3074820,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-28T20:38:12.000Z","date":"2020-07-26","kind":"tax_withholding","acquired":false,"shares":1876,"price":8.8,"value":16508.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,876 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":305118,"source":{"system":"sec-edgar","filing":"0001567619-20-013825","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013825/doc1.xml","form_type":"4"}},{"id":3078718,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-21T23:33:06.000Z","date":"2020-07-18","kind":"tax_withholding","acquired":false,"shares":1483,"price":9.21,"value":13658.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,483 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":306994,"source":{"system":"sec-edgar","filing":"0001567619-20-013546","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013546/doc1.xml","form_type":"4"}},{"id":3078717,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-21T23:33:06.000Z","date":"2020-07-17","kind":"tax_withholding","acquired":false,"shares":2131,"price":9.46,"value":20159.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,131 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":308477,"source":{"system":"sec-edgar","filing":"0001567619-20-013546","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013546/doc1.xml","form_type":"4"}},{"id":3080442,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-18T01:35:57.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":160237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 14, 2021, such that 25% of the options will vest on each of July 14, 2021, 2022, 2023 and 2024."}],"balance_after":160237,"derivative":{"exercise_price":9.92,"exercise_date":"2021-07-14","expiration_date":"2030-07-14","underlying":"Common Stock","underlying_shares":160237},"source":{"system":"sec-edgar","filing":"0001567619-20-013438","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013438/doc1.xml","form_type":"4"}},{"id":3080441,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2020-07-18T01:35:57.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":108871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":108871,"derivative":{"underlying":"Common Stock","underlying_shares":108871},"source":{"system":"sec-edgar","filing":"0001567619-20-013438","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013438/doc1.xml","form_type":"4"}},{"id":3080440,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-07-18T01:35:57.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":54435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 54,435 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 54,435 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 14, 2021, such that 25% of the restricted stock units will vest on each of July 14, 2021, 2022, 2023 and 2024."}],"balance_after":310608,"source":{"system":"sec-edgar","filing":"0001567619-20-013438","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920013438/doc1.xml","form_type":"4"}},{"id":3180612,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-04-07T20:11:33.000Z","date":"2020-04-04","kind":"tax_withholding","acquired":false,"shares":4245,"price":10.23,"value":43426.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 4,245 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 4, 2016."}],"balance_after":256173,"source":{"system":"sec-edgar","filing":"0001567619-20-007647","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761920007647/doc1.xml","form_type":"4"}},{"id":3224507,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-05T21:36:36.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":8095,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62082,"source":{"system":"sec-edgar","filing":"0000899243-20-007207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000089924320007207/doc4.xml","form_type":"4"}},{"id":3387224,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-10-28T12:13:43.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":15000,"price":14.19,"value":212850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.15 to $14.22, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1."}],"balance_after":260418,"source":{"system":"sec-edgar","filing":"0001567619-19-020025","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919020025/doc1.xml","form_type":"4"}},{"id":3391006,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2019-10-18T22:30:58.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":50139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":50139,"derivative":{"underlying":"Common Stock","underlying_shares":50139},"source":{"system":"sec-edgar","filing":"0001567619-19-019773","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919019773/doc1.xml","form_type":"4"}},{"id":3434483,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2019-08-20T01:59:26.000Z","date":"2019-07-12","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On April 1, 2016, the reporting person received a target grant of 250,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 200,000 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 1, 2016, the reporting person received a target grant of 250,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 200,000 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 1, 2016, the reporting person received a target grant of 250,000 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 200,000 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001567619-19-017316","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919017316/doc1.xml","form_type":"4"}},{"id":3434482,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-20T01:59:26.000Z","date":"2019-07-12","kind":"tax_withholding","acquired":false,"shares":96140,"price":21.68,"value":2084315.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 96,140 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on April 1, 2016."}],"balance_after":245418,"source":{"system":"sec-edgar","filing":"0001567619-19-017316","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919017316/doc1.xml","form_type":"4"}},{"id":3434481,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-20T01:59:26.000Z","date":"2019-07-12","kind":"exercise","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 200,000 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on April 1, 2016."}],"balance_after":341558,"source":{"system":"sec-edgar","filing":"0001567619-19-017316","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919017316/doc1.xml","form_type":"4"}},{"id":3449167,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-02T20:33:16.000Z","date":"2019-07-27","kind":"tax_withholding","acquired":false,"shares":1752,"price":20.91,"value":36634.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,752 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":141558,"source":{"system":"sec-edgar","filing":"0001567619-19-015724","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919015724/doc1.xml","form_type":"4"}},{"id":3449166,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-08-02T20:33:16.000Z","date":"2019-07-26","kind":"tax_withholding","acquired":false,"shares":1826,"price":20.89,"value":38145.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,826 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":143310,"source":{"system":"sec-edgar","filing":"0001567619-19-015724","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919015724/doc1.xml","form_type":"4"}},{"id":3455981,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-07-25T20:56:54.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":1444,"price":21.53,"value":31089.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,444 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":145136,"source":{"system":"sec-edgar","filing":"0001567619-19-015209","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919015209/doc1.xml","form_type":"4"}},{"id":3458526,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-20T01:25:57.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":83967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":83967,"derivative":{"exercise_price":21.54,"exercise_date":"2020-07-17","expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":83967},"source":{"system":"sec-edgar","filing":"0001567619-19-015039","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919015039/doc1.xml","form_type":"4"}},{"id":3458525,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-07-20T01:25:57.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":25104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 25,104 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 25,104 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":146580,"source":{"system":"sec-edgar","filing":"0001567619-19-015039","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919015039/doc1.xml","form_type":"4"}},{"id":3560308,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-04-08T20:09:39.000Z","date":"2019-04-04","kind":"tax_withholding","acquired":false,"shares":4232,"price":22.95,"value":97124.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 4,232 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on April 4, 2016."}],"balance_after":121476,"source":{"system":"sec-edgar","filing":"0001567619-19-008523","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000156761919008523/doc1.xml","form_type":"4"}},{"id":3626266,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:15:38.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53987,"source":{"system":"sec-edgar","filing":"0000899243-19-005209","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000089924319005209/doc4.xml","form_type":"4"}},{"id":3859045,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-30T22:56:06.000Z","date":"2018-07-27","kind":"tax_withholding","acquired":false,"shares":1752,"price":21.42,"value":37527.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,752 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":125708,"source":{"system":"sec-edgar","filing":"0001140361-18-034274","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036118034274/doc1.xml","form_type":"4"}},{"id":3859932,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-27T23:58:24.000Z","date":"2018-07-26","kind":"tax_withholding","acquired":false,"shares":1826,"price":21.88,"value":39952.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,826 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":127460,"source":{"system":"sec-edgar","filing":"0001140361-18-033942","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036118033942/doc1.xml","form_type":"4"}},{"id":3863651,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2018-07-21T01:36:53.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":34938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":34938,"derivative":{"underlying":"Common Stock","underlying_shares":34938},"source":{"system":"sec-edgar","filing":"0001140361-18-033093","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036118033093/doc1.xml","form_type":"4"}},{"id":3863650,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-21T01:36:53.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":55651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 18, 2019, such that 25% of the options will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":55651,"derivative":{"exercise_price":20.93,"exercise_date":"2019-07-18","expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":55651},"source":{"system":"sec-edgar","filing":"0001140361-18-033093","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036118033093/doc1.xml","form_type":"4"}},{"id":3863649,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2018-07-21T01:36:53.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":17469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 17,469 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 17,469 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 18, 2019, such that 25% of the restricted stock units will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":129286,"source":{"system":"sec-edgar","filing":"0001140361-18-033093","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036118033093/doc1.xml","form_type":"4"}},{"id":4008195,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T21:35:44.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":7911,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":48634,"source":{"system":"sec-edgar","filing":"0000899243-18-006651","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000089924318006651/doc4.xml","form_type":"4"}},{"id":4249395,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Performance Right","published_at":"2017-07-28T21:38:54.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":44184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":44184,"derivative":{"underlying":"Common Stock","underlying_shares":44184},"source":{"system":"sec-edgar","filing":"0001140361-17-029179","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036117029179/doc1.xml","form_type":"4"}},{"id":4249394,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-07-28T21:38:54.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":77627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":77627,"derivative":{"exercise_price":16.55,"exercise_date":"2018-07-26","expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":77627},"source":{"system":"sec-edgar","filing":"0001140361-17-029179","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036117029179/doc1.xml","form_type":"4"}},{"id":4249393,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-28T21:38:54.000Z","date":"2017-07-27","kind":"tax_withholding","acquired":false,"shares":1958,"price":16.36,"value":32032.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,958 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":111817,"source":{"system":"sec-edgar","filing":"0001140361-17-029179","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036117029179/doc1.xml","form_type":"4"}},{"id":4249392,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-28T21:38:54.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":22092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 22,092 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 22,092 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":113775,"source":{"system":"sec-edgar","filing":"0001140361-17-029179","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036117029179/doc1.xml","form_type":"4"}},{"id":4253249,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-21T22:43:07.000Z","date":"2017-07-21","kind":"purchase","acquired":true,"shares":5000,"price":15.79,"value":78950.0,"ownership":{"direct":true},"balance_after":91683,"source":{"system":"sec-edgar","filing":"0001140361-17-028409","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036117028409/doc1.xml","form_type":"4"}},{"id":4253248,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28775,"kind":"person","name":"Clemmer James C","position":1,"cik":"0001476700","reported_name":"Clemmer James C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-07-21T22:43:07.000Z","date":"2017-07-20","kind":"purchase","acquired":true,"shares":20000,"price":15.64,"value":312800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $15.54 to $15.70, inclusive.  The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."}],"balance_after":86683,"source":{"system":"sec-edgar","filing":"0001140361-17-028409","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1476700/000114036117028409/doc1.xml","form_type":"4"}}],"next_cursor":"2017-07-21T22:43:07.000000Z,4253248"}